Current Applications for Overcoming Resistance to Targeted Therapies

Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Szewczuk, Myron R. (Editor, http://id.loc.gov/vocabulary/relators/edt), Qorri, Bessi (Editor, http://id.loc.gov/vocabulary/relators/edt), Sambi, Manpreet (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2019.
Edition:1st ed. 2019.
Series:Resistance to Targeted Anti-Cancer Therapeutics, 20
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Introduction to the Acquisition of Resistance to Targeted Therapy
  • Targeting the Tumor Microenvironment to Overcome Resistance to Targeted Therapy
  • Current Challenges and Applications of Oncolytic Viruses in Overcoming Resistance to Therapies in Cancer
  • Novel Methods to Overcome Acquired Resistance to Immunotherapy
  • Therapies to Overcome Multidrug-Resistant Receptors
  • Overcoming Resistance to PARP Inhibition
  • Novel Methods of Overcoming HER2 Therapy Resistance in Breast Cancer
  • Emerging Novel Therapies for Overcoming Resistance to Targeted Therapies
  • Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy
  • Nanomedicine and Drug Delivery Systems in Overcoming Resistance to Targeted Therapy
  • Index.